Showing 1 - 3 results of 3 for search 'Gundram Jung', query time: 0.01s Refine Results
  1. 1
    Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castration-resistant prostate carcinoma

    Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castrat... by Gundram Jung, Jonas S Heitmann, Juliane S Walz, Martin Pflügler, Joseph Kauer, Richard F Schlenk, Helmut R Salih

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies

    Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies by Melanie Märklin, Gundram Jung, Jonas S Heitmann, Helmut R Salih, Martina Svenja Lutz, Boris Klimovich, Stefanie Maurer, Latifa Zekri, Clemens Hinterleitner

    Published 2022-02-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies

    Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies by Hans-Georg Rammensee, Melanie Märklin, Gundram Jung, Jonas S Heitmann, Joseph Kauer, Helmut R Salih, Latifa Zekri, Lukas Osburg, Sebastian Hörner, Stefanie Müller

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: